Athanasios Bakalakos

8PUBLICATIONS
39CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 06, 2026
Gene-specific reclassification patterns of variants in hypertrophic cardiomyopathy.

|Feb 06, 2026
Cardiovascular Morbidity and Mortality in Fabry Disease.

Emanuele Monda, Athanasios Bakalakos, Annamaria Del Franco

|Jun 27, 2025
Tailored therapeutics for cardiomyopathies.

Athanasios Bakalakos, Emanuele Monda, Perry Mark Elliott

|Apr 30, 2024
Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease.

Emanuele Monda, Athanasios Bakalakos, Robin Lachmann

|Mar 27, 2024
Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block.

Douglas Cannie, Kush Patel, Alexandros Protonotarios

|Dec 04, 2023
Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies.

Emanuele Monda, Gaetano Diana, Francesca Graziani

Pageof 2

Frequent Collaborators

5 joint publications

Perry Mark Elliott

3 joint publications

Emanuele Monda

3 joint publications

Giuseppe Limongelli

2 joint publications

Francesca Graziani